Fundraising Fox
Monument Biosciences
Founded 2022 · 12 employees on LinkedIn · 2 known investors
Find your way into Monument Biosciences
Sign up to see every warm intro you have to Monument Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Monument Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Monument Biosciences is a biotechnology company developing disease-modifying drugs for Alzheimer's Disease and Related Dementias (ADRD). It explores diverse therapeutic modalities and combination therapies targeting neurodegeneration for patients and their families.
Investors · 2
Dolby Family Ventureslisted by Dolby Family VenturesSan Francisco
How we know: Dolby Family Ventures's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
Elevate Ventureslisted by Elevate VenturesIndianapolis · $20K – $2M
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Monument Biosciences do?
- Monument Biosciences is a biotechnology company developing disease-modifying drugs for Alzheimer's Disease and Related Dementias (ADRD). It explores diverse therapeutic modalities and combination therapies targeting neurodegeneration for patients and their families.
- Who are Monument Biosciences's investors?
- Monument Biosciences's investors include Dolby Family Ventures, Elevate Ventures.